The Advisory Committee on Immunization Practices has updated its vaccination recommendations for immunocompetent adults aged 65 years or older to extend the interval between receipt of the Prevnar 13 and Pneumovax 23...
Emerging infectious diseases are affecting public health and economies globally. Still living in the COVID-19 pandemic and now seeing another global public health emergency with monkeypox, the world must also be on full...
Individuals with Down syndrome have less-frequent viral infections, but when present, these infections lead to more severe disease. New findings publishing on October 14 in the journal Immunity show that this is caused...
Researchers at Georgia State University say their findings, published July 14 in the International Journal of Nanomedicine, suggest their nano-engineered vaccine induces long-term protection against respiratory...
The Independent Task Force on COVID-19 and other Pandemics announced that their report “Pandemic Origins and a One Health Approach to Preparedness and Prevention: Solutions Based on SARS-CoV-2 and Other RNA Viruses” has...
University of Maryland School of Medicine researchers have identified how multiple genes of SARS-CoV-2 affect disease severity, which could lead to new ways in how we develop future vaccines or develop newer treatments...
As of late September 2022, nearly 78% of U.S. adults but only 31% of children ages 5 to 11 had completed their primary series of vaccinations against COVID-19, according to health authorities. In an open-access article...
A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced. The vaccine showed success in stimulating production of rare immune cells...
New analysis by scientists at Scripps Research and University of Brussels finds that climate change and other factors could soon make deadly Lassa fever a much bigger public health problem in Africa In the study, which...
Neither money nor other nudges are enough to persuade vaccine-hesitant people to get the COVID-19 vaccine, a new USC study shows. The findings, published recently in the journal Vaccine, suggest the standard public...